2024 ASCO Annual Meeting
2024 ASCO Annual Meeting
Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 1 – 3:00 PM CDT
location_onHall D1
2024 ASCO Annual Meeting
Rapid Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 3 – 8:00 AM CDT
location_onS406
Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.
8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
ASCO Presentations 2024
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.5¢ | $9.418K | 80.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 174654 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 190989 | 5 |
View Market Depth
| Last trade - 13.26pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.8¢ |
Change
0.005 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.0¢ | 11.5¢ | 36717 | ||
| Last updated 13.48pm 28/05/2024 ? | |||||
| SPL (ASX) Chart |